Biocortech Overview

  • Founded
  • 2001
  • Status
  • Private
  • Latest Deal Type
  • Accelerator/​Inc
  • Investors
  • 1

Biocortech General Information


Developer of drug safety screening and in vitro blood test applications. The company engages in the development of novel therapeutics for neuropsychiatric disease, focusing on areas including depression, schizophrenia, cognitive deficits due to the ageing process, and sexual dysfunction.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Therapeutic Devices
Other Industries
Primary Office
  • 28, rue du Dr. Roux
  • 75015 Paris
  • France
+33 01 00 00 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Biocortech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator 01-Jan-2003 Completed Startup
To view Biocortech’s complete valuation and funding history, request access »

Biocortech Executive Team (2)

Name Title Board Seat Contact Info
Jean-François Pujol Chief Scientific Officer
You’re viewing 1 of 2 executive team members. Get the full list »

Biocortech Board Members (1)

Name Representing Role Since
Andre Choulika Ph.D Self Board Member 000 0000
To view Biocortech’s complete board members history, request access »

Biocortech Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
The Institut Pasteur Accelerator/Incubator 000 0000 000000 0
To view Biocortech’s complete investors history, request access »